Adam Koppel's Net Worth
Adam Koppel's net worth is estimated to be at least $60,338,999.00 as of 05/02/2026. CoreStreet's estimation of Adam Koppel's net worth is based on their sale of stock and current holding of stock.
Adam Koppel is Director at Kailera Therapeutics, Inc. Common Stock. They have executed at least 6 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,562,500 units of KLRA stock on 04/20/2026. Their biggest sale was on 06/06/2016 when they sold 555 units of Biogen Inc stock for $160,950.00. They typically trade 1 times per year.
Total value of insider buys:
- $60,149,999.00
Total value of insider sells:
- $189,000.00
Most recent insider trade:
- April 20, 2026
Adam Koppel's Insider Trading History
| Kailera Therapeutics, Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 20, 2026 | Director | 1,562,500 | $16.00 | Buy | $25,000,000.00 |
| Aptinyx Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 14, 2020 | Director | 3,333,333 | $3.00 | Buy | $9,999,999.00 |
June 25, 2018 | Director | 400,000 | $16.00 | Buy | $6,400,000.00 |
| Biogen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 6, 2016 | EVP | 555 | $290.00 | Sell | $160,950.00 |
April 6, 2016 | EVP | 102 | $275.00 | Sell | $28,050.00 |
| PTC Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 25, 2013 | Director | 1,250,000 | $15.00 | Buy | $18,750,000.00 |